#Nephbluesky
LightNews LightNews
divyaveerssneph.bsky.social
🤩 Excited for the #WCN2025 at Delhi 🇮🇳
👀 Forward to the 'Interconnected kidney' session

Please take 3 mins to fill in this survey and contribute your views in this topic at #ISNWCN
@myadla.bsky.social @theisn.org

#Nephsky #Nephbluesky
#Medsky #Liver #hepatology #Nephrology
February 4, 2025 at 5:31 AM
hardik4u24.bsky.social
💡 Who should get #Tolvaptan in #ADPKD?

A stepwise approach to identifying rapid disease progression 📈

✔️ eGFR decline >3 ml/min/yr? Treat!
✔️ Imaging/genetic risk? Assess!

📊 @BMCNephrology

🔗 doi.org/10.1186/s128...

#Nephrology #Kidney #NephBlueSky
February 24, 2025 at 4:11 PM
divyaveerssneph.bsky.social
🆕Once-Monthly💉 Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial | New England Journal of Medicine www.nejm.org/doi/full/10....

combines GLP-1 receptor agonism & glucose-dependent insulinotropic polypeptide (GIP) receptor antagonism

#Nephrology #Nephsky #Nephbluesky #Medsky
Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial | NEJM
Maridebart cafraglutide (known as MariTide) is a long-acting peptide–antibody conjugate that combines glucagon-like peptide-1 receptor agonism and glucose-dependent insulinotropic polypeptide recep...
www.nejm.org
June 24, 2025 at 7:01 PM
divyaveerssneph.bsky.social
👀👇A smart concise table of most of the #Statistics used in #Medical #Research

#Nephrology #Nephbluesky #Nephsky #Medsky #MedX #NephEd
#NephNuggets
January 18, 2025 at 2:32 PM
divyaveerssneph.bsky.social
Thank you @arvindcanchi.bsky.social for ur kind words 🙏
My team's work on #kidney function in #liver disease is 🎯 to completion. Hoping to publish final results from our @icmr.bsky.social funded study soon.
#ISNWCN
#Hepatonephrology
#Nephrology #Nephsky #Nephbluesky #Medsky
👀results of our pilot 📃
https://www.jcehepatology.com/article/S0973-6883(24)01131-9/abstract
February 11, 2025 at 2:49 PM
divyaveerssneph.bsky.social
📢Honoured to be🥇author of 📖Chapter on MPGN and C3GN in 'Grand Rounds in #Nephrology 2️⃣' released at #ISNWCN #WCN2025
🙌 Prof. V Jha for the opportunity& mentorship 🙏🙏🙏
Grateful to Prof. R Kasi Visweshwaran sir for "Grand 📖"
#Nephbluesky #Nephsky #Medbluesky #Medsky #NephEd
February 11, 2025 at 2:37 PM
divyaveerssneph.bsky.social
🚨Podcast for #everyone in #Hindi
Thanks to #Akashwani #Chandigarh for inviting me
#educate #general #public 🗣️ on #kidney #diseases, #answer queries & burst myths on #dialysis & #transplant
#Nephrology #NephEd #Nephsky #Medsky #Nephbluesky #MedX

🙏Thanks Prof. Dr. HS Kohli and my Department
https://youtu.be/9Btud6NA6f4?feature=shared
May 27, 2025 at 4:58 PM
divyaveerssneph.bsky.social
On this #InternationalDayofWomenandGirlsinScience , I must thank my awesome research team who give their 💯 dedication to work 🌟
Blessed to have met 👇😇 souls 🙏🙏🙏
Thanks to @ICMR.bsky.social for funding our ideas
#Nephsky
#Nephbluesky #nephrology #Medtbluesky #Medsky #Science #researcher
#girlpower
https://pmc.ncbi.nlm.nih.gov/articles/PMC11302601/ https://indianjnephrol.org/comparison-of-standard-and-global-coagulation-tests-in-hemodialysis-patients/ https://www.jcehepatology.com/article/S0973-6883(24)01131-9/abstract
February 11, 2025 at 6:50 PM
divyaveerssneph.bsky.social
#ECNeph @myadla.bsky.social @theisn.org

Check out another rare cause of anemia post kidney transplantation ➡️ a case report from IPGMER, Kolkata, India... My alma mater❤️

Tacrolimus induced pure red cell aplasia!!!

#Nephsky #Nephbluesky

academic.oup.com/ckj/article/...
December 6, 2024 at 5:57 PM
divyaveerssneph.bsky.social
A moving and compassionate read this festive season : 'Demedicalising the process of Dying'
A vital matter for all of humanity... Not Doctors alone

@AnitaHannig 👌📄🙏

#Nephsky #Nephbluesky #NephEd #Medsky #Medbluesky #Deathwish
https://www.bmj.com/content/387/bmj.q2703.full.pdf
December 24, 2024 at 6:28 AM
myadla.bsky.social
Hello #Nephbluesky! We're excited to invite you to our inaugural #ECNeph session featuring @divyaveerssneph.bsky.social. Discussing a post-transplant case with a double whammy . Share your insights. Don't forget to include #ECNeph in all your posts.
December 5, 2024 at 12:44 PM
theisn.org
Happening Today on Bluesky !
We invite all #Nephbluesky friends to join us for #ECNeph interesting case discussion at 9:30 PM IST @myadla.bsky.social @arunkumarnephro.bsky.social @nihalbashir.bsky.social @kajareeg.bsky.social
March 7, 2025 at 6:25 AM
meganbaker.bsky.social
Excited to share our review just published in @jclinical-invest.bsky.social today — Adding insult to injury: the spectrum of tubulointerstitial responses in acute kidney injury!!

🔗 www.jci.org/articles/vie...

#Nephbluesky #Nephsky #Medsky #Nephrology #Kidney
March 17, 2025 at 4:35 PM
divyaveerssneph.bsky.social
🆕 🥇FDA approved therapy for C3 Glomerulopathy
Iptacopan : inhibitor of the alternative complement pathway by specifically binding to and inhibiting factor B
#Hope for #kidney #disease
#Great time to be in #Nephrology
#Nephsky #Nephbluesky #Medsky #Medbluesky #Nephronuggets
March 21, 2025 at 12:04 PM
divyaveerssneph.bsky.social
Chromogranin A is a curious entity!

Thank you @drsumanbehera.bsky.social @myadla.bsky.social for the extraordinary #ECNeph case
Chromogranin A Nephropathy / tubulopathy

bmcnephrol.biomedcentral.com/articles/10....
#Nephsky #Nephbluesky
March 29, 2025 at 2:34 PM
divyaveerssneph.bsky.social
🆕📃👀 ANCA negative pauci immune GN ▶️A large series
⬆️ Chronicity and advanced diseased at diagnosis
🫘 limited
⬇️ Relapses, yet poorer prognosis due to advanced disease 😨
@theisn.org
#Nephbluesky #Nephsky #Nephrology #NephEd #Medbluesky #Medsky
https://www.kireports.org/article/S2468-0249(25)00122-6/fulltext
April 2, 2025 at 8:24 PM
divyaveerssneph.bsky.social
📢Scientific program at #ISNWCN 2025 is available at ISN Academy‼️🤩
🙏Thanks @ISNWCN @vjha.bsky.social & Prof. Masaomi N for the opportunity to be a speaker!
👀 complexities of #kidney function in #cirrhosis ➡️The interconnected Kidney theme
#Nephbluesky #Nephsky @theisn.org #NephEd
#hepatonephrology
https://www.jcehepatology.com/article/S0973-6883(24)01131-9/abstract
February 17, 2025 at 6:53 PM
divyaveerssneph.bsky.social
🌟Looking forward to 👀 all for one of my favorite themes 'The Interconnected Kidney' at #WCN2025 at #Delhi 🇮🇳
🤩 Excited to share my thoughts and my team's work on #Kidney function in #Liver #disease

@myadla.bsky.social @theisn.org #ISNWCN
#Nephrology #Nephsky #Nephbluesky
January 26, 2025 at 7:42 AM
divyaveerssneph.bsky.social
📢Join us for #Nephrology #academic feast organized by #WIN india #Kerala chapter on 25th Feb 2025 , 8:00 IST
👀 forward to 🪑sesion on 🧬 in 🫘 #Kidney diseases and interacting with the awesome minds 🌟
#Nephbluesky #Nephsky #NephEd
#womeininnephrology 🇮🇳
February 24, 2025 at 10:25 AM
divyaveerssneph.bsky.social
That's #rare indeed
Polyoma virus crescents !
Thanks for sharing @jzrenalpath.bsky.social
#Nephsky #nephbluesky #renopath
jzrenalpath.bsky.social Jonathan Zuckerman MD PhD @jzrenalpath.bsky.social · May 6
A polyoma virus 'crescents' in a case of BK nephropathy in a kidney transplant patient. SV40 demonstrates parietal epithelial cell positivity on deeper levels. BK viremia >3 million recently. #renalpath #pathsky #nephsky
May 10, 2025 at 8:10 PM
divyaveerssneph.bsky.social
📢 Nephrologists, Hepatologists and Physicians dealing with #kidney #disease in #liver cirrhosis. Please give 5 mins of your valuable time to fill this survey.
It'll help us understand current practices
#Nephbluesky #Nephsky #Medsky
Results will be present @ #WCN2025 @myadla.bsky.social
@theisn
https://docs.google.com/forms/d/e/1FAIpQLSdQet0SKAv4W0iLQUNAVu43WuQSS3qWdnFYIKnz6m0jWDvKAQ/viewform
February 1, 2025 at 3:22 PM
divyaveerssneph.bsky.social
🆕📃sheds🔦 on Anti PLA2R seronegative relapses in Membranous Nephropathy

💡Relapse without 📈Ab, though uncommon
▶️Ab test by IIF ➕ ELISA may help
💊💉 similar to other relapses
#Nephbluesky #Nephsky #NephEd
#Nephronuggets #Medsky

@theisn.org
Bensouna I, Delafosse M, Cartery C, Stehlé T, Rabate C, Boullenger F, Buob D, Boffa JJ, Dahan K, Esteve E. Recurrence of Phospholipase A2 Receptor–Associated Membranous Nephropathy in the Absence of Serum Anti-Phospholipase A2 Receptor Antibodies Reappearance. Kidney International Reports. 2025 Mar 1;10(3):952-5. BibTeX EndNote
March 30, 2025 at 5:33 PM